Is there a future for CYP1A2 pharmacogenetics in the optimal dosing of clozapine?

Can Jun Ruan; Jose De Leon

doi:10.2217/pgs-2020-0015

Is there a future for CYP1A2 pharmacogenetics in the optimal dosing of clozapine?

Research output: Contribution to journal › Review article › peer-review

44 Scopus citations

Original language	English
Pages (from-to)	369-373
Number of pages	5
Journal	Pharmacogenomics
Volume	21
Issue number	6
DOIs	https://doi.org/10.2217/pgs-2020-0015
State	Published - Apr 2020

Keywords

Asian continental ancestry group/genetics
drug interactions
gene frequency/genetics
inflammation
obesity
phenotype
sex
smoking

ASJC Scopus subject areas

Molecular Medicine
Genetics
Pharmacology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.2217/pgs-2020-0015

Cite this

@article{8633c9e0ab6242f3a696e49390beae85,

title = "Is there a future for CYP1A2 pharmacogenetics in the optimal dosing of clozapine?",

keywords = "Asian continental ancestry group/genetics, drug interactions, gene frequency/genetics, inflammation, obesity, phenotype, sex, smoking",

author = "Ruan, {Can Jun} and Leon, {Jose De}",

year = "2020",

month = apr,

doi = "10.2217/pgs-2020-0015",

language = "English",

volume = "21",